A case of spindle cell dominant histiocytic sarcoma showing a complete remission after first-line chemotherapy with doxorubicin and ifosfamide

Author:

Nakamura Yusuke1,Takemasa Akihiro1,Kushima Yoshitomo1,Soda Sayo1,Ikeda Naoya1,Arai Ryo1,Chibana Kazuyuki1,Nakazato Yoshimasa2,Yokose Tomoyuki3,Shimizu Yasuo1,Niho Seiji1

Affiliation:

1. Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, Tochigi, Japan

2. Department of Pathology, Dokkyo Medical University School of Medicine, Tochigi, Japan

3. Department of Pathology, Kanagawa Cancer Center, Yokohama, Japan

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Reference19 articles.

1. Grogan TM, Pileri SA, Chan JKC, Weiss LM, Fletcher C, Swerdlow SH, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Switzerland: WHO Press; 2008. p. 356–7.

2. Histiocytic Sarcoma : An Updated Literature Review Based on the 2008 WHO Classification

3. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163

4. Primary histiocytic sarcoma arising in the head and neck with predominant spindle cell component

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3